AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MICROBA LIFE SCIENCES LTD

0.105

+0.01212.90%

Volume:339.63K

Turnover:33.20K

Market Cap:54.08M

PE:-3.31

High:0.105

Open:0.093

Low:0.093

Close:0.093

Loading ...

Overview Company News Filings

Microba Announces Landmark Gi Study Results From Over 4,600 Patients

THOMSON REUTERS

Microba Life Sciences Confirms MetaXplore Test May Help Identify Underlying Gastrointestinal Issues, Shares Fall 9%

MT Newswires Live

BUZZ-Australia's Microba Life Sciences slumps on weak Q3 revenue

Microba Life Sciences Ltd - FY25 Revenue Expected to Be in the Range of a$15.25M - a$16.25M

THOMSON REUTERS

Microba Says Test Studies Detect 60% More Pathogens Missed by Routine Methods in Bowel Disease Patients

MT Newswires Live

Some Confidence Is Lacking In Microba Life Sciences Limited (ASX:MAP) As Shares Slide 29%

Simply Wall St.

BRIEF-Microba Life Sciences Says Loss For The Half-Year Attributable A$5.7 Million

Microba Life Sciences Ltd - Loss for the Half-Year Attributable a$5.7 Mln

THOMSON REUTERS

Government Adjusts Distribution of 3-Kg LPG for SMEs

3 ASX Penny Stocks With Market Caps Up To A$300M

Simply Wall St.

BRIEF-Microba Life Sciences Posts H1 Revenue Of A$8.08M

Microba Life Sciences - H1 FY25 Revenue of a$8.08M

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAP.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","market":"AU","secType":"STK","nameCN":"MICROBA LIFE SCIENCES LTD","latestPrice":0.105,"timestamp":1752819120000,"preClose":0.093,"halted":0,"volume":339628,"delay":0,"nameEN":"MICROBA LIFE SCIENCES LTD","floatShares":250807396,"shares":515029773,"eps":-0.031703,"marketStatus":"Market Closed","change":0.012,"latestTime":"07-18 16:12:00 AEST","open":0.093,"high":0.105,"low":0.093,"amount":33198,"amplitude":0.129032,"askPrice":0.105,"askSize":17608,"bidPrice":0.098,"bidSize":30000,"shortable":3,"etf":0,"ttmEps":-0.031703,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"listingDate":1648994400000,"exchange":"ASX","adjPreClose":0.093,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":1.2773578782126034,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAP.AU\",,,,,undefined,":{"symbol":"MAP.AU","floatShares":250807396,"roa":"-24.29%","roe":"-33.42%","lyrEps":-0.048647,"volumeRatio":1.2773578782126034,"shares":515029773,"dividePrice":0,"high":0.105,"amplitude":0.129032,"preClose":0.093,"low":0.093,"week52Low":0.082,"pbRate":"1.52","psRate":"3.20","week52High":0.325,"institutionHeld":0,"latestPrice":0.105,"committee":0.260292,"eps":-0.031703,"divideRate":0,"volume":339628,"delay":0,"ttmEps":-0.031703,"open":0.093,"prevYearClose":0.195,"prevWeekClose":0.094,"prevMonthClose":0.085,"prevQuarterClose":0.085,"fiveDayClose":0.094,"twentyDayClose":0.115,"sixtyDayClose":0.185},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAP.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535832225","title":"Microba Announces Landmark Gi Study Results From Over 4,600 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2535832225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535832225?lang=en_us&edition=fundamental","pubTime":"2025-05-15 10:12","pubTimestamp":1747275122,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA7KWSYK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2535983190","title":"Microba Life Sciences Confirms MetaXplore Test May Help Identify Underlying Gastrointestinal Issues, Shares Fall 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535983190","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535983190?lang=en_us&edition=fundamental","pubTime":"2025-05-14 13:46","pubTimestamp":1747201619,"startTime":"0","endTime":"0","summary":"Microba Life Sciences  said that preliminary results from an analysis of over 4,600 MetaXplore GI Plus test results show that the test can support clinicians to identify and address underlying gastrointestinal issues that often go undetected by conventional testing, according to a Wednesday Australian bourse filing.The MetaXploreGI Plus is a comprehensive test for the assessment and management of lower gastrointestinal disorders.The test revealed findings, such as abnormalities in gut bacteria, signs of infection, or markers of inflammation or insufficiency, in over 70% of cases. In a separate study, 65.5% of the patients reported improvements in the symptoms following clinician-directed recommendations informed by MetaXplore.The firm's shares fell 9% in recent trading on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2531725098","title":"BUZZ-Australia's Microba Life Sciences slumps on weak Q3 revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2531725098","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531725098?lang=en_us&edition=fundamental","pubTime":"2025-04-30 10:54","pubTimestamp":1745981672,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Microba Life Sciences slumps on weak Q3 revenue** Shares of Microba Life Sciences MAP.AX fall 17.8% to A$0.185** Stock set for its weakest session since October 23, 2023- if current trends hold** Health sciences co posts a 15% decline in Q3 revenue compared to last year ** But, co sees FY25 revenue to be up 26%-34% from last year** Co set for its strongest month since January** About 559,491 shares change hands, 3.7x the 30-day average of 152,712 shares** Stock down 5.1% YTD, including current session's moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250430:nL4N3R809E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2531712081","title":"Microba Life Sciences Ltd - FY25 Revenue Expected to Be in the Range of a$15.25M - a$16.25M","url":"https://stock-news.laohu8.com/highlight/detail?id=2531712081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531712081?lang=en_us&edition=fundamental","pubTime":"2025-04-30 07:24","pubTimestamp":1745969065,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R727P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"gpt_icon":0},{"id":"2531108719","title":"Microba Says Test Studies Detect 60% More Pathogens Missed by Routine Methods in Bowel Disease Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2531108719","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531108719?lang=en_us&edition=fundamental","pubTime":"2025-04-30 06:35","pubTimestamp":1745966135,"startTime":"0","endTime":"0","summary":"Microba Life Sciences  said that studies of its MetaPanel gastrointestinal pathogen test found that 40% of inflammatory bowel disease  patients tested positive for gastrointestinal pathogens, and over 60% of the pathogens would have been missed using standard diagnostic methods, according to a Tuesday statement by the company.MetaPanel was designed to identify pathogens not detected by conventional tests to help clinicians avoid unnecessary treatments, reduce treatment failures, and minimize the need for surgery, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","MAP.AU","IBD"],"gpt_icon":0},{"id":"2517480437","title":"Some Confidence Is Lacking In Microba Life Sciences Limited (ASX:MAP) As Shares Slide 29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480437?lang=en_us&edition=fundamental","pubTime":"2025-03-07 04:44","pubTimestamp":1741293864,"startTime":"0","endTime":"0","summary":"The Microba Life Sciences Limited ( ASX:MAP ) share price has softened a substantial 29% over the previous 30 days...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-map/microba-life-sciences-shares/news/some-confidence-is-lacking-in-microba-life-sciences-limited","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2514222024","title":"BRIEF-Microba Life Sciences Says Loss For The Half-Year Attributable A$5.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514222024","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514222024?lang=en_us&edition=fundamental","pubTime":"2025-02-26 09:19","pubTimestamp":1740532791,"startTime":"0","endTime":"0","summary":"BRIEF-Microba Life Sciences Says Loss For The Half-Year Attributable A$5.7 MillionFeb 26  - Microba Life Sciences Ltd MAP.AX:LOSS FOR THE HALF-YEAR ATTRIBUTABLE A$5.7 MILLIONHY REVENUES FROM ORDINARY ACTIVITIES A$8.1 MILLIONFurther company coverage: MAP.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PG0YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2514477360","title":"Microba Life Sciences Ltd - Loss for the Half-Year Attributable a$5.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2514477360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514477360?lang=en_us&edition=fundamental","pubTime":"2025-02-26 06:16","pubTimestamp":1740521776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG0YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","MAP.AU"],"gpt_icon":0},{"id":"2509261710","title":"Government Adjusts Distribution of 3-Kg LPG for SMEs","url":"https://stock-news.laohu8.com/highlight/detail?id=2509261710","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509261710?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:42","pubTimestamp":1738928575,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Deputy Minister of Energy and Mineral Resources  Yuliot Tanjung explained that the distribution of 3-kilogram liquefied petroleum gas  for small and medium-sized enterprises  will not be regulated by a specific policy. Instead, the mechanism will be based on the business permit data owned by the business owners.\"This is not a specific regulation, so we will look at the micro-business permits they already have in the form of NIB . With this data, we can determine the needs of each business, the type of business, and its location,\" said Yuliot when met at his office on Friday, February 7, 2025.Previously, Minister of ESDM Bahlil Lahadalia stated that SMEs will still have access to subsidized LPG, but with specific regulations. \"For SMEs, we still have to provide for them. So, we will also set the rules. Indeed, they will be given differently from regular household consumption,\" he said while inspecting an LPG depot in Pekanbaru.","market":"other","thumbnail":"https://statik.tempo.co/data/2025/02/07/id_1375547/1375547_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/02/07/id_1375547/1375547_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1972813/government-adjusts-distribution-of-3-kg-lpg-for-smes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4588","BK7124","LPG","MAP.AU","BK4585","BK4144"],"gpt_icon":0},{"id":"2509926536","title":"3 ASX Penny Stocks With Market Caps Up To A$300M","url":"https://stock-news.laohu8.com/highlight/detail?id=2509926536","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509926536?lang=en_us&edition=fundamental","pubTime":"2025-02-06 07:06","pubTimestamp":1738796773,"startTime":"0","endTime":"0","summary":"The Australian share market is poised for a positive opening, with the ASX 200 expected to rise following a week marked by geopolitical developments and economic data releases. In such fluctuating conditions, investors often look beyond established giants to explore opportunities in smaller companies. Penny stocks, though an older term, remain relevant as they represent smaller or newer companies that can offer value and growth potential. This article will explore three penny stocks that stand out for their financial strength and potential appeal amidst current market trends.Click here to see the full list of 1,031 stocks from our ASX Penny Stocks screener.We're going to check out a few of the best picks from our screener tool.Overview: Gold Hydrogen Limited focuses on the discovery, exploration, and development of hydrogen and helium gas in Australia, with a market cap of A$93.45 million.ASX:GHY Financial Position Analysis as at Feb 2025. Overview: Microba Life Sciences Limited operat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-penny-stocks-market-230613066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7070","SKS.AU","BK7132","BK7055","GTN.AU","BK7124","ANG.AU","HLO.AU","XAO.AU","EVO.AU","XKO.AU","XJO.AU","BK7045","SHA.AU","NIC.AU","GHY.AU","BK7088","BK7095","BK7083","MXI.AU","IGL.AU","LBL.AU","BK7023","BK7077","MAP.AU"],"gpt_icon":0},{"id":"2507657649","title":"BRIEF-Microba Life Sciences Posts H1 Revenue Of A$8.08M","url":"https://stock-news.laohu8.com/highlight/detail?id=2507657649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507657649?lang=en_us&edition=fundamental","pubTime":"2025-01-29 09:20","pubTimestamp":1738113613,"startTime":"0","endTime":"0","summary":"BRIEF-Microba Life Sciences Posts H1 Revenue Of A$8.08MJan 29 (Reuters) - Microba Life Sciences Ltd MAP.AX:H1 FY25 REVENUE OF A$8.08MFurther company coverage: MAP.AX ((Reuters.Briefs@thomsonreuters.com;;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nFWN3OO1SF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAP.AU"],"gpt_icon":0},{"id":"2507521698","title":"Microba Life Sciences - H1 FY25 Revenue of a$8.08M","url":"https://stock-news.laohu8.com/highlight/detail?id=2507521698","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507521698?lang=en_us&edition=fundamental","pubTime":"2025-01-29 05:58","pubTimestamp":1738101503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nFWN3OO1SF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAP.AU","BK7124"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAP.AU\",params:#limit:5,,,undefined,":[{"date":"2025-04-30","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745971200000,"name":null,"time":"","dateTimestamp":1745935200000,"actualEps":null},{"date":"2024-10-28","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1730070000000,"name":null,"time":"","dateTimestamp":1730034000000,"actualEps":null},{"date":"2024-07-25","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721865600000,"name":null,"time":"","dateTimestamp":1721829600000,"actualEps":null},{"date":"2024-04-23","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1713830400000,"name":null,"time":"","dateTimestamp":1713794400000,"actualEps":null},{"date":"2024-01-30","symbol":"MAP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1706569200000,"name":null,"time":"","dateTimestamp":1706533200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAP.AU\",market:\"AU\",,,undefined,":[]}}